Drug Profile
LF 070165C
Alternative Names: LF 70165CLatest Information Update: 22 Oct 1997
Price :
$50
*
At a glance
- Originator Groupe Fournier
- Class Antihyperlipidaemics; Sterols
- Mechanism of Action Cholesterol inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypercholesterolaemia
Most Recent Events
- 22 Oct 1997 Discontinued-Preclinical for Hypercholesterolaemia in France (Unknown route)
- 23 Jun 1995 Preclinical development for Hypercholesterolaemia in France (Unknown route)